117 related articles for article (PubMed ID: 18705009)
1. [PD-L1 expression in circulating dendritic cells of patients with chronic hepatitis B].
Peng GP; Sun W; Wu W; Sun Z; Tan XF; Li SP; Chen Z
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 37(4):364-72. PubMed ID: 18705009
[TBL] [Abstract][Full Text] [Related]
2. [PD-1 expression in peripheral T cells of patients with HBV infection and its significance].
Peng GP; Sun W; Sun Z
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 Nov; 36(6):553-60. PubMed ID: 18067228
[TBL] [Abstract][Full Text] [Related]
3. Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion.
Evans A; Riva A; Cooksley H; Phillips S; Puranik S; Nathwani A; Brett S; Chokshi S; Naoumov NV
Hepatology; 2008 Sep; 48(3):759-69. PubMed ID: 18697210
[TBL] [Abstract][Full Text] [Related]
4. Intrahepatic levels of PD-1/PD-L correlate with liver inflammation in chronic hepatitis B.
Chen J; Wang XM; Wu XJ; Wang Y; Zhao H; Shen B; Wang GQ
Inflamm Res; 2011 Jan; 60(1):47-53. PubMed ID: 20661763
[TBL] [Abstract][Full Text] [Related]
5. [Programmed death-1 (PD-1) and PD-L1 expression during antiviral treatment of chronic hepatitis B].
Xie DY; Lin BL; Chen FJ; Deng H; Chong YT; Zhang XH; Gao ZL
Zhonghua Gan Zang Bing Za Zhi; 2010 Sep; 18(9):646-50. PubMed ID: 20943073
[TBL] [Abstract][Full Text] [Related]
6. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B.
Fisicaro P; Valdatta C; Massari M; Loggi E; Biasini E; Sacchelli L; Cavallo MC; Silini EM; Andreone P; Missale G; Ferrari C
Gastroenterology; 2010 Feb; 138(2):682-93, 693.e1-4. PubMed ID: 19800335
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal fluctuations in PD1 and PD-L1 expression in association with changes in anti-viral immune response in chronic hepatitis B.
Wenjin Z; Chuanhui P; Yunle W; Lateef SA; Shusen Z
BMC Gastroenterol; 2012 Aug; 12():109. PubMed ID: 22894700
[TBL] [Abstract][Full Text] [Related]
8. Programmed death-1 expression is associated with the disease status in hepatitis B virus infection.
Ye P; Weng ZH; Zhang SL; Zhang JA; Zhao L; Dong JH; Jie SH; Pang R; Wei RH
World J Gastroenterol; 2008 Jul; 14(28):4551-7. PubMed ID: 18680238
[TBL] [Abstract][Full Text] [Related]
9. PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients.
Peng G; Li S; Wu W; Tan X; Chen Y; Chen Z
Mol Immunol; 2008 Feb; 45(4):963-70. PubMed ID: 17868872
[TBL] [Abstract][Full Text] [Related]
10. [Hepatitis B e antigen from chronic hepatitis B patients induces Th1/Th2 cytokine imbalance in vitro].
Han YP; Li J; Jiang LF; Xu QQ; Liu B; Dong L; Chen N; Kong LH; Xie FR; Huang ZH
Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):584-9. PubMed ID: 24119737
[TBL] [Abstract][Full Text] [Related]
11. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
[TBL] [Abstract][Full Text] [Related]
12. Circulating CD4+CD25high regulatory T cells and expression of PD-1 and BTLA on CD4+ T cells in patients with chronic hepatitis B virus infection.
Nan XP; Zhang Y; Yu HT; Li Y; Sun RL; Wang JP; Bai XF
Viral Immunol; 2010 Feb; 23(1):63-70. PubMed ID: 20121403
[TBL] [Abstract][Full Text] [Related]
13. Intrahepatic PD-1/PD-L1 up-regulation closely correlates with inflammation and virus replication in patients with chronic HBV infection.
Xie Z; Chen Y; Zhao S; Yang Z; Yao X; Guo S; Yang C; Fei L; Zeng X; Ni B; Wu Y
Immunol Invest; 2009; 38(7):624-38. PubMed ID: 19811426
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of Dynamics of Programmed Death Ligand-1 Expression on Circulating CD14
Huang ZY; Xu P; Li JH; Zeng CH; Song HF; Chen H; Zhu YB; Song YY; Lu HL; Shen CP; Zhang XG; Wu MY; Wang XF
Viral Immunol; 2017 Apr; 30(3):224-231. PubMed ID: 28005469
[TBL] [Abstract][Full Text] [Related]
15. [PD-1 up-regulation influenced apoptosis of HBV-specific CD8 T cells in patients with acute resolved hepatitis B].
Xu B; Zhang Z; Shi Y; Chen XY; Wang FS
Zhonghua Yi Xue Za Zhi; 2009 May; 89(17):1158-61. PubMed ID: 19595077
[TBL] [Abstract][Full Text] [Related]
16. Functional Exhaustion of HBV-Specific CD8 T Cells Impedes PD-L1 Blockade Efficacy in Chronic HBV Infection.
Ferrando-Martinez S; Snell Bennett A; Lino E; Gehring AJ; Feld J; Janssen HLA; Robbins SH
Front Immunol; 2021; 12():648420. PubMed ID: 34589081
[TBL] [Abstract][Full Text] [Related]
17. [Expressions and significance of B7-H1 and programmed death-1 in lymphocytes from patients with chronic hepatitis B virus infection].
Li YG; Chen LE; Chen GF; Wang FS
Zhonghua Gan Zang Bing Za Zhi; 2007 Oct; 15(10):738-41. PubMed ID: 17963598
[TBL] [Abstract][Full Text] [Related]
18. Viral infection parameters not nucleoside analogue itself correlates with host immunity in nucleoside analogue therapy for chronic hepatitis B.
Li CZ; Hu JJ; Xue JY; Yin W; Liu YY; Fan WH; Xu H; Liang XS
World J Gastroenterol; 2014 Jul; 20(28):9486-96. PubMed ID: 25071343
[TBL] [Abstract][Full Text] [Related]
19. Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.
Fisicaro P; Valdatta C; Massari M; Loggi E; Ravanetti L; Urbani S; Giuberti T; Cavalli A; Vandelli C; Andreone P; Missale G; Ferrari C
Gastroenterology; 2012 Dec; 143(6):1576-1585.e4. PubMed ID: 22929808
[TBL] [Abstract][Full Text] [Related]
20. Natural course of chronic hepatitis B is characterized by changing patterns of programmed death type-1 of CD8-positive T cells.
Liang XS; Zhou Y; Li CZ; Wan MB
World J Gastroenterol; 2010 Feb; 16(5):618-24. PubMed ID: 20128032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
